Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), β-lactamase inhibitors(Beta Lactamase inhibitors), Cell wall inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CN (09 Apr 2009), |
Regulation- |
Molecular FormulaC18H20N8NaO8S3 |
InChIKeyKFQRYHQOZUTRQJ-BBJOQENWSA-N |
CAS Registry104376-79-6 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Bacterial Infections | CN | 09 Apr 2009 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bacterial lower respiratory infection | Phase 3 | CN | 16 Apr 2015 | |
Genitourinary tract infection | Phase 3 | CN | 16 Apr 2015 | |
Acute Bronchitis | Phase 2 | CN | 17 May 2011 | |
Acute pyelonephritis | Phase 2 | CN | 17 May 2011 | |
Bronchiectasis | Phase 2 | CN | 17 May 2011 | |
Community Acquired Pneumonia | Phase 2 | CN | 17 May 2011 | |
Complicated urinary tract infection | Phase 2 | CN | 17 May 2011 | |
Hospital-acquired pneumonia | Phase 2 | CN | 17 May 2011 | |
Pulmonary Disease, Chronic Obstructive | Phase 2 | CN | 17 May 2011 | |
Lower Respiratory Tract Infections | Phase 1 | CN | 22 Jul 2010 |